News | June 7, 2022

Cambridge Pharma Opens On The Cambridge Research Park

Source: SMC Ltd.

Cambridge, UK – SMC Ltd., a leading solutions provider in the manufacturing of pharmaceutical and medical devices, announces the opening of Cambridge Pharma a new business offering pharmaceutical development services, including sterile fill-finish. The new 20,000 sq ft facility located at the Cambridge Research Park, UK, includes a purpose-built sterile fill-finish facility, a process development laboratory, and an analytical laboratory. Services include process development and scale up, sterile fill finish for clinical trials, QC and stability testing and QP release of clinical trials supplies.

Chetan N. Patel, Owner and CEO of SMC Group, has a strategic vision for the Company, “We value pharmaceutical partnerships and continue to expand services in development, manufacturing and analytical testing to help accelerate drug product development. We are proud to launch ‘Cambridge Pharma’ as a part of our continued focus, growth, and commitment to pharmaceutical products and services.”

The sterile fill finish facility is designed to meet up-to-date regulatory requirements and includes a state-of-the-art dynamic and independent HVAC systems and two clean rooms. Each clean room is equipped with isolators and fill finish equipment to support batch sizes from 100 units to 15,000 units in vials, cartridges, or syringes. Cambridge Pharma’s industrialization engineers can take a customer’s laboratory scale formulation and develop a process for clinical trials in phases one to three including process development and filling of viscous formulations, suspensions, and gels. Nonstandard primary drug containers can be accommodated, and container closure integrity tests and associated equipment can also be developed.

The experienced QC and QA teams can undertake stability and QC testing and the QPs can release clinical trial supplies. Cambridge Pharma project managers ensure program schedules are respected to meet pharma companies target trial start dates.

Barbara Lead, Cambridge Pharma CEO, said: “I am really proud of our new facilities and the experience and expertise of our teams. We can provide a range of pharmaceutical development services and we have experience with difficult to fill formulations. We aim to provide an excellent service to customers for clinical trial supplies which are always on the critical path to market.”

Tim Holden, Cambridge Pharma’s Commercial Director, added: “Our principal aim is to meet the challenging schedules Pharma clients face when planning clinical trial supplies. Our process development laboratory means we can support this, it certainly gives us an edge in completing timely technology transfer. We have the equipment and facilities designed specifically for smaller flexible manufacturing runs. Specializing in this service ensures that development timelines can be minimized, and cost savings can be made by our customers. We are very proud that our new facility has ecofriendly features which means we can help Pharma and Biotech companies meet their sustainability targets too.”

Further information:
Cambridge Pharma Limited
Barbara Lead / Tim Holden
+44 (0)1223 736 221

Media inquiries:
Allerton Communications
Peter Curtain
+44 (0)20 3633 1730 / +44 (0)7733 301 707

About Cambridge Pharma Limited

Cambridge Pharma Ltd. specializes in providing the safest sterile drugs products for clinical use and small-scale requirements. They offer a fast, flexible fill-finish service specifically designed to meet the needs of clinical trials and stability studies including process development, stability testing and QC analysis. In-house expertise will support novel drug development from pre-clinical to commercialization. Their state-of-the-art GMP facility situated at the heart of Europe’s biggest biotech and pharma cluster has dynamic Intelligent clean room control helping pharma companies meet their environmental sustainability targets.

About SMC Group

SMC Group comprises of SMC Ltd., Oval Medical Technologies Ltd. and Cambridge Pharma Ltd. With over 34 years of medical manufacturing experience and facilities in California, Wisconsin, Massachusetts, Ohio, UK, India and Costa Rica. The SMC group provides contract manufacturing services to the Medical device and Diagnostics industries and “end-to-end” integrated services for clinical and commercial manufacturing of combination products for pharmaceutical customers. Visit us at, and . For further information please visit

Source: SMC Ltd.